These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2102019)

  • 1. A short review of biotechnological methods of relevance to modern vaccine development.
    Helland DE; Hey AW
    Scand J Infect Dis Suppl; 1990; 76():32-8. PubMed ID: 2102019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel vaccines from biotechnology.
    Rogan D; Babiuk LA
    Rev Sci Tech; 2005 Apr; 24(1):159-74. PubMed ID: 16110886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New approaches to vaccine development.
    Doblander K; Lubitz W
    J Biotechnol; 1996 Jan; 44(1-3):xi-xiii. PubMed ID: 8717378
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biotechnology and animal health].
    Desmettre P
    Rev Sci Tech; 1993 Jun; 12(2):355-68. PubMed ID: 8400382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular approaches for safer and stronger vaccines.
    Del Giudice G; Rappuoli R
    Schweiz Med Wochenschr; 1999 Nov; 129(46):1744-8. PubMed ID: 10603647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modern trends in the development of bacterial vaccines for human use.
    Hungerer KD; Robbel L
    Behring Inst Mitt; 1988 Apr; (82):360-71. PubMed ID: 3044344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Viral vaccines produced by gene technology and synthesis].
    Hess RG
    Tierarztl Prax; 1986; 14(1):9-14. PubMed ID: 2424142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approaches in vaccine development.
    Leclerc C
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):329-41. PubMed ID: 12818620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. United States Pharmacopeia activities in the area of vaccines, virology and immunology.
    Morris TS
    Vaccine; 2005 Mar; 23(17-18):2311-3. PubMed ID: 15755617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of vaccine research and development: the human immunodeficiency virus (HIV).
    Girard MP; Osmanov SK; Kieny MP
    Vaccine; 2006 May; 24(19):4062-81. PubMed ID: 16530298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against equine influenza: quid novi?
    Paillot R; Hannant D; Kydd JH; Daly JM
    Vaccine; 2006 May; 24(19):4047-61. PubMed ID: 16545507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using plant cells as influenza vaccine substrates.
    Chichester JA; Haaheim LR; Yusibov V
    Expert Rev Vaccines; 2009 Apr; 8(4):493-8. PubMed ID: 19348564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New concepts in vaccine development in malaria.
    Kanoi BN; Egwang TG
    Curr Opin Infect Dis; 2007 Jun; 20(3):311-6. PubMed ID: 17471043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine strategies against human cytomegalovirus infection.
    Zhong J; Khanna R
    Expert Rev Anti Infect Ther; 2007 Jun; 5(3):449-59. PubMed ID: 17547509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine manufacturing and technology: from biotechnological platforms to syntethic epitopes, current viepoint.
    Ignateva GA
    Patol Fiziol Eksp Ter; 2016; 60(4):143-7. PubMed ID: 29244936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New technologies for vaccines.
    Dorner F; Eibl J; Barrett PN
    Wien Klin Wochenschr; 1999 Mar; 111(5):199-206. PubMed ID: 10226350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of marker vaccine and differential diagnostic test technology.
    Henderson LM
    Biologicals; 2005 Dec; 33(4):203-9. PubMed ID: 16257545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of respiratory syncytial virus vaccine development.
    Polack FP; Karron RA
    Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S65-73. PubMed ID: 14730272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.